mBio
(Oct 2021)
Across Functional Boundaries: Making Nonneutralizing Antibodies To Neutralize HIV-1 and Mediate Fc-Mediated Effector Killing of Infected Cells
Jonathan Richard,
Dung N. Nguyen,
William D. Tolbert,
Romain Gasser,
Shilei Ding,
Dani Vézina,
Shang Yu Gong,
Jérémie Prévost,
Gabrielle Gendron-Lepage,
Halima Medjahed,
Suneetha Gottumukkala,
Andrés Finzi,
Marzena Pazgier
Affiliations
Jonathan Richard
Centre de Recherche du CHUM, Montréal, Québec, Canada
Dung N. Nguyen
Infectious Disease Division, Department of Medicine of Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
William D. Tolbert
Infectious Disease Division, Department of Medicine of Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
Romain Gasser
Centre de Recherche du CHUM, Montréal, Québec, Canada
Shilei Ding
Centre de Recherche du CHUM, Montréal, Québec, Canada
Dani Vézina
ORCiD
Centre de Recherche du CHUM, Montréal, Québec, Canada
Shang Yu Gong
Centre de Recherche du CHUM, Montréal, Québec, Canada
Jérémie Prévost
Centre de Recherche du CHUM, Montréal, Québec, Canada
Gabrielle Gendron-Lepage
Centre de Recherche du CHUM, Montréal, Québec, Canada
Halima Medjahed
Centre de Recherche du CHUM, Montréal, Québec, Canada
Suneetha Gottumukkala
Infectious Disease Division, Department of Medicine of Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
Andrés Finzi
ORCiD
Centre de Recherche du CHUM, Montréal, Québec, Canada
Marzena Pazgier
ORCiD
Infectious Disease Division, Department of Medicine of Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
DOI
https://doi.org/10.1128/mBio.01405-21
Journal volume & issue
Vol. 12,
no. 5
Abstract
Read online
Highly conserved epitopes within the coreceptor binding site (CoRBS) and constant region 1 and 2 (C1-C2 or cluster A) are only available for antibody recognition after the HIV-1 Env trimer binds host cell CD4; therefore, they are not accessible on virions and infected cells, where the expression of CD4 is downregulated. Here, we have developed new antibody fusion molecules in which domains 1 and 2 of soluble human CD4 are linked with monoclonal antibodies of either the CoRBS or cluster A specificity.
WeChat QR code
Close